These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24982084)

  • 1. In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India.
    Kathuria S; Singh PK; Meis JF; Chowdhary A
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5613-6. PubMed ID: 24982084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
    Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis.
    Rodríguez-Arellanes G; Taylor ML; Pérez-Torres A; Curiel-Quesada E; Vargas-Mendoza CF; Martínez-Rivera MA
    Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
    van Duin D; Casadevall A; Nosanchuk JD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.
    Nakai T; Uno J; Ikeda F; Tawara S; Nishimura K; Miyaji M
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1376-81. PubMed ID: 12654673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the efficacy of micafungin in the treatment of histoplasmosis using two North American strains of Histoplasma capsulatum.
    Hage CA; Connolly P; Horan D; Durkin M; Smedema M; Zarnowski R; Smith P; Wheat LJ
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4447-50. PubMed ID: 21670186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Brilhante RS; Caetano EP; Sidrim JJ; Cordeiro RA; Camargo ZP; Fechine MA; Lima RA; Castelo Branco DS; Marques FJ; Mesquita JR; Lima DT; Monteiro AJ; Rocha MF
    Mycoses; 2013 May; 56(3):397-401. PubMed ID: 23205615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model.
    Kohler S; Wheat LJ; Connolly P; Schnizlein-Bick C; Durkin M; Smedema M; Goldberg J; Brizendine E
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1850-4. PubMed ID: 10858342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
    Brilhante RS; Fechine MA; Mesquita JR; Cordeiro RA; Rocha MF; Monteiro AJ; Lima RA; Caetano ÉP; Pereira JF; Castelo-Branco DS; Camargo ZP; Sidrim JJ
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):484-8. PubMed ID: 22703696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal Susceptibility Testing and Drug Discovery in the Dimorphic Fungus Histoplasma Capsulatum.
    Rappleye CA
    Methods Mol Biol; 2023; 2658():43-52. PubMed ID: 37024694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of yeast and mycelial phases of Histoplasma capsulatum to amphotericin B and actinomycin D.
    Cheung SC; Medoff G; Schlessinger D; Kobayashi GS
    Antimicrob Agents Chemother; 1975 Oct; 8(4):498-503. PubMed ID: 1190756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
    Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
    Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
    Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum.
    de Aguiar Cordeiro R; de Farias Marques FJ; de Aguiar Cordeiro R; da Silva MR; Donato Maia Malaquias A; Silva de Melo CV; Mafezoli J; Ferreira de Oliveira Mda C; Nogueira Brilhante RS; Gadelha Rocha MF; Pinheiro Gomes Bandeira Tde J; Costa Sidrim JJ
    Antimicrob Agents Chemother; 2014 May; 58(5):2504-11. PubMed ID: 24514090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis S; Medoff G
    Antimicrob Agents Chemother; 1986 Apr; 29(4):660-2. PubMed ID: 3010852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
    Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the therapeutic activity of caspofungin compared with the amphotericin B in an animal experimental model of histoplasmosis in hamster (Mesocrisetus auratus).
    Finquelievich J; Landaburu MF; Pinoni V; Iovannitti CA
    Rev Iberoam Micol; 2011; 28(4):155-8. PubMed ID: 21473926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
    Serfling A; Wohlrab J; Deising HB
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3672-6. PubMed ID: 17620378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.